Download interactions: TXT MITAB-2.5
Interaction | Interactor | Experiments | Homologs | Category | Interaction Score |
Confidence |
---|---|---|---|---|---|---|
RU17
U1 small nuclear ribonucleoprotein 70 kDa |
3 |
20 |
Small-scale |
0.861 | High |
|
SRS31
Serine/arginine-rich splicing factor RS31 |
3 |
18 |
Small-scale |
0.858 | High |
|
RSZ21
Serine/arginine-rich splicing factor RSZ21 |
2 |
17 |
High-throughput |
0.800 | High |
|
SRS41
Serine/arginine-rich splicing factor RS41 |
2 |
19 |
High-throughput |
0.800 | High |
|
ORRM2
Organelle RRM domain-containing protein 2, mitochondrial |
2 |
20 |
High-throughput |
0.800 | High |
|
RZ22A
Serine/arginine-rich splicing factor RSZ22A |
2 |
19 |
High-throughput |
0.800 | High |
|
SR45
Serine/arginine-rich splicing factor SR45 |
2 |
20 |
Small-scale |
0.754 | High |
|
AFC3
Serine/threonine-protein kinase AFC3 |
2 |
20 |
High-throughput |
0.715 | High |
|
SR34
Serine/arginine-rich-splicing factor SR34 |
1 |
20 |
Small-scale |
0.681 | High |
|
SRC28
Serine/arginine-rich SC35-like splicing factor SCL28 |
1 |
20 |
Small-scale |
0.681 | High |
|
CYP59
Peptidyl-prolyl cis-trans isomerase CYP59 |
1 |
4 |
Small-scale |
0.681 | High |
|
SRC30
Serine/arginine-rich SC35-like splicing factor SCL30 |
1 |
20 |
Small-scale |
0.681 | High |
|
U1135
U11/U12 small nuclear ribonucleoprotein 35 kDa protein |
1 |
20 |
Small-scale |
0.681 | High |
|
SL30A
Serine/arginine-rich SC35-like splicing factor SCL30A |
1 |
20 |
Small-scale |
0.681 | High |
|
RSZ33
Serine/arginine-rich splicing factor RS2Z33 |
1 |
20 |
Small-scale |
0.680 | High |
|
Q9CAG1
cyclin-dependent kinase |
1 |
5 |
High-throughput |
0.618 | High |
|
ARR14
Two-component response regulator ARR14 |
2 |
1 |
High-throughput |
0.566 | High |
|
MOS14
Transportin MOS14 |
1 |
15 |
Small-scale |
0.555 | High |
|
UBQ3
Polyubiquitin 3 [Cleaved into: Ubiquitin] |
1 |
16 |
High-throughput |
0.479 | High |
|
KNAT1
Homeobox protein knotted-1-like 1 |
1 |
0 |
High-throughput |
0.251 | Low |
Service provided by Combinatics, Japan
Last updated: 15 Jul 2024